StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.33−0.01 (-0.75%)

Close on Nov 18, 2026Market cap $65.46MP/E –Yield –

MediciNova pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MediciNova's pe ratio was 26.8× on Jan 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jan 30, 201526.8×+5.3
2014Dec 31, 201421.6×–

More MediciNova figures

See a number that looks wrong?